- Home
- FATE vs WYY Comparison
FATE vs WYY Comparison
Compare FATE & WYY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | FATE | WYY |
|---|---|---|
| Founded | 2007 | 1991 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | EDP Services |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 125.6M | 107.8M |
| IPO Year | 2013 | 2005 |
Fundamental Metrics
Financial Performance| Metric | FATE | WYY |
|---|---|---|
| Price | $2.88 | $11.51 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 6 | 3 |
| Target Price | $4.10 | ★ $8.67 |
| AVG Volume (30 Days) | ★ 4.9M | 479.5K |
| Earning Date | 05-14-2026 | 05-14-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 29.88 | N/A |
| EPS | N/A | ★ 0.01 |
| Revenue | $6,646,000.00 | ★ $150,545,364.00 |
| Revenue This Year | N/A | $14.41 |
| Revenue Next Year | N/A | $11.41 |
| P/E Ratio | ★ N/A | $1,221.00 |
| Revenue Growth | N/A | ★ 5.59 |
| 52 Week Low | $0.91 | $2.80 |
| 52 Week High | $3.23 | $24.30 |
Technical Indicators
Market Signals| Indicator | FATE | WYY |
|---|---|---|
| Relative Strength Index (RSI) | 57.59 | 40.94 |
| Support Level | $1.01 | $5.06 |
| Resistance Level | $2.88 | $24.30 |
| Average True Range (ATR) | 0.30 | 1.61 |
| MACD | -0.01 | -0.62 |
| Stochastic Oscillator | 68.40 | 5.40 |
Price Performance
Historical ComparisonAbout FATE Fate Therapeutics Inc.
Fate Therapeutics Inc is a clinical-stage biopharmaceutical company based in the United States. The company is engaged in the development of programmed cellular immunotherapies for cancer and autoimmune disorders. The company's cell therapy pipeline is comprised of NK- and T-cell immuno-oncology programs, including off-the-shelf engineered product candidates derived from clonal master iPSC lines, and immuno-regulatory programs, including product candidates to prevent life-threatening complications in patients.
About WYY WidePoint Corporation
WidePoint Corp is a provider of Technology Management as a Service (TMaaS) that consists of federally certified communications management, identity management, interactive bill presentment and analytics, and an Information Technology as a Service solution. Its solutions include Telecom Lifecycle Management, Digital billing communications solutions, and Mobile and Identity management. Geographically, the company generates a majority of its revenue from the United States and the rest from Europe.